# Phase 2 Daily Monitoring — Day 2
**Date:** 2026-06-11 (Thursday) | **Pre-Market Snapshot** | **Data as of:** 2026-06-10 close

---

## ⚠️ Priority Alerts

| # | Ticker | Alert | Detail |
|---|--------|-------|--------|
| 🔴 | **DNTH** | GAP -9.64% | Volume 4,705,500 (2.27x avg) — MANUAL REVIEW |
| 🔴 | **DRUG** | GAP -9.20% | Volume 708,300 (1.49x avg) — MANUAL REVIEW |
| 🔴 | Drawdown Gate | CONDITIONAL TRIP | -6.70pp vs XBI (threshold: -2.00pp) — verify with actual equity |
| 🟡 | **PRAX** | -28.81% from entry | Tier B, headwind, T+20 catalyst |
| 🟡 | **DRUG** | -28.82% from entry | Tier A, headwind |
| 🟡 | **CMPS** | -24.56% from entry | Tier C, tailwind, T+19 catalyst |

> **Robinhood MCP tools are not available in this execution environment.** Account equity and buying power cannot be fetched automatically. The drawdown gate calculation is based on yfinance price averages (not capital-weighted equity) — authoritative gate determination requires actual account equity from Robinhood.

---

## Portfolio Performance Summary

| Metric | Value |
|--------|-------|
| Monitoring Day | 2 of ~15 (Phase 2) |
| Positions | 15 (EW, 3.33% each) |
| Avg P&L vs Entry (2026-06-01) | **-10.27%** (yfinance prices) |
| Positions Positive | 2 (URGN, SYRE) |
| Positions Negative | 13 |
| Positions Flagged | 7 |
| Prior Day Equity (baseline) | $85.43 → -14.73% |
| XBI since entry | -3.57% |
| Portfolio vs XBI (price-avg) | **-6.70pp** |

---

## Full Position Table

| Ticker | Entry | Close (06/10) | P&L vs Entry | Day Chg | Volume | Vol/Avg | Cat Days | Status |
|--------|-------|---------------|--------------|---------|--------|---------|----------|--------|
| COGT | $35.24 | $31.38 | -10.95% | -1.88% | 2,510K | 1.00x | T+20 | 🟡 FLAG |
| **DNTH** | $90.94 | $76.42 | -15.97% | **-9.64%** | **4,706K** | **2.27x** | T+19 | 🔴 GAP |
| NRIX | $17.51 | $15.30 | -12.62% | -2.17% | 2,535K | 0.25x | T+51 | 🟡 FLAG |
| URGN | $26.43 | $28.00 | **+5.94%** | -0.64% | 617K | 0.87x | T+82 | ✅ OK |
| ALMS | $20.30 | $20.06 | -1.18% | +0.25% | 1,184K | 0.82x | T+20 | ✅ OK |
| SYRE | $70.48 | $75.08 | **+6.53%** | -1.78% | 981K | 0.82x | T+11 | ✅ OK |
| RVMD | $161.26 | $144.19 | -10.59% | -3.58% | 3,282K | 1.12x | T+293 | 🟡 FLAG |
| CMPS | $14.62 | $11.03 | **-24.56%** | -2.04% | 2,159K | 0.74x | T+19 | 🔴 >20% |
| SLDB | $7.26 | $6.61 | -8.95% | +0.61% | 1,134K | 1.15x | T+126 | ✅ OK |
| **DRUG** | $86.48 | $61.56 | **-28.82%** | **-9.20%** | 708K | **1.49x** | T+143 | 🔴 GAP |
| STOK | $30.51 | $28.48 | -6.65% | -3.03% | 534K | 1.21x | T+111 | ✅ OK |
| PRAX | $338.06 | $240.66 | **-28.81%** | -3.86% | 408K | 0.76x | T+20 | 🔴 >20% |
| TRVI | $13.99 | $13.40 | -4.22% | -1.40% | 932K | 0.95x | T+19 | ✅ OK |
| ERAS | $14.68 | $13.37 | -8.92% | -0.30% | 3,655K | 0.77x | T+173 | ✅ OK |
| XENE | $53.66 | $51.34 | -4.32% | -2.75% | 1,259K | 0.98x | T+51 | ✅ OK |

---

## Governance Gates

| Gate | Value | Threshold | Status |
|------|-------|-----------|--------|
| Drawdown vs XBI (price-avg) | -6.70pp | ≤ -2.00pp | ⚠️ CONDITIONAL TRIP |
| Drawdown vs XBI (equity) | UNFETCHABLE | ≤ -2.00pp | ❓ MANUAL CHECK |
| IC Observable | NO_DATA | — | Expected ~2026-06-17 |
| 13F Jaccard | 0.875 | ≥ 0.70 | ✅ PASS |
| Emergency Exit | ARMED | — | Standing |

**Drawdown Gate Note:** The price-average method (-6.70pp) exceeds the -2.00pp hard-exit threshold. However, Day 1 baseline showed 0.00pp using actual equity — suggesting the gate is designed for capital-weighted returns, not price averages. Using actual account equity ($100.19 → $85.43 = -14.73% portfolio vs XBI -3.57% = -11.16pp) also trips the gate. **MANUAL DETERMINATION REQUIRED** — this may be a genuine gate-trip situation or the methodology differs. Do not trigger automatic phase end without operator confirmation.

---

## Top Gainers / Losers

**Top 3 Gainers (vs entry 2026-06-01)**
1. **SYRE** +6.53% | $70.48 → $75.08 | T+11 catalyst (tailwind)
2. **URGN** +5.94% | $26.43 → $28.00 | T+82 (tailwind)
3. **ALMS** -1.18% | $20.30 → $20.06 | T+20 (tailwind)

**Top 3 Losers (vs entry 2026-06-01)**
1. **DRUG** -28.82% | $86.48 → $61.56 | GAP day on 2026-06-10
2. **PRAX** -28.81% | $338.06 → $240.66 | Tier B headwind
3. **CMPS** -24.56% | $14.62 → $11.03 | Tier C

---

## Catalyst Watch

### Near-Term (≤14 days)
| Ticker | Days | Mom | Tier | Action |
|--------|------|-----|------|--------|
| **SYRE** | T+11 | tailwind | B | ⚡ Monitor positioning; positive P&L (+6.53%) |

### Horizon (15–21 days)
| Ticker | Days | Mom | Tier | Notes |
|--------|------|-----|------|-------|
| COGT | T+20 | headwind | A | -10.95% entry |
| DNTH | T+19 | tailwind | A | URGENT — -9.64% gap yesterday |
| ALMS | T+20 | tailwind | A | Near flat (-1.18%) |
| CMPS | T+19 | tailwind | C | -24.56% — significant loss before catalyst |
| PRAX | T+20 | headwind | B | -28.81% — significant loss before catalyst |
| TRVI | T+19 | neutral | C | -4.22% — manageable |

---

## Benchmark Comparison

| Metric | Value |
|--------|-------|
| XBI day change (06/09→06/10) | -1.93% |
| XBI since entry (06/01) | -3.57% ($133.62 → $128.85) |
| Portfolio avg since entry | -10.27% |
| Portfolio vs XBI | -6.70pp |

Portfolio is significantly underperforming XBI since execution. Broad biotech weakness (XBI -3.57%) explains part of the drag, but idiosyncratic losses in DRUG, PRAX, CMPS account for the excess.

---

## Operational Status

| Check | Status |
|-------|--------|
| Price data currency | ✅ 2026-06-10 close (yfinance) |
| Snapshot generation | ✅ 2026-06-11 pre-market |
| Portfolio immutability | ✅ No trades executed |
| Unauthorized trades | ✅ None |
| Robinhood MCP | ❌ Unavailable — install for live account data |

---

## Required Actions (Today)

1. **[URGENT] DNTH news check** — -9.64% on 2.27x volume is a significant move. Check: ClinicalTrials.gov for any DNTH study updates, SEC 8-K filings, and biotech news sources. Could be clinical data (T+19 catalyst), safety signal, or sector rotation.

2. **[URGENT] DRUG news check** — -9.20% on 1.49x volume. Bright Minds Biosciences: check for clinical update, company announcement, or analyst action.

3. **[REQUIRED] Drawdown gate determination** — Log into Robinhood account 802349084 and check current equity. Compare to $100.19 start equity. If equity confirms >-2.00pp vs XBI, operator must decide: invoke hard exit or document override rationale.

4. **SYRE T+11** — Catalyst within 14 days. Position +6.53% — monitor for pre-readout drift. Review catalyst details to confirm event timing.

5. **Day 5 Checkpoint (2026-06-14)** — Weekly summary collection. Prepare Layer B signal aggregation.

6. **IC First Print (~2026-06-17)** — Critical governance decision approaching. Prepare extend vs. revert analysis framework.

---

## Governance Checkpoints

| Checkpoint | Date | Days | Status |
|------------|------|------|--------|
| Day 1 | 2026-06-10 | 0 | ✅ BASELINE CAPTURED |
| **Day 2** | **2026-06-11** | **1** | **← YOU ARE HERE** |
| Day 5 | 2026-06-14 | 4 | Weekly summary |
| IC Print + Decision | ~2026-06-17 | ~6 | **CRITICAL** — extend or revert? |
| Day 30 | ~2026-07-01 | ~19 | Governance review |

---

## Data Notes

- **Price source:** yfinance (2026-06-10 close). Values may differ modestly from Robinhood execution data.
- **Account equity:** Not refreshed — using 2026-06-10 baseline values ($85.43). Live equity requires Robinhood MCP.
- **Catalyst days:** Decremented by 1 from Day 1 baseline (T+N → T+(N-1)).
- **Drawdown gate:** Two methods produce different absolute values; both trip the threshold. Manual determination required.

---

*Generated: 2026-06-11 pre-market | Phase 2 Monitoring Day 2 | Read-only observation — no trades*
